Terms: = Kidney tumors AND ALDH2, ALDHI, 217, ENSG00000111275, ALDH-E2, P05091, MGC1806, ALDM AND Prognosis
15 results:
1. Prognostic evaluation based on radiological morphological characteristic for tumors larger than 7 cm in renal cell carcinoma.
Huang J; Dai C; Zhang S; Li Y; He M; Xu P; Zhou J; Guo J; Wang H
J Cancer Res Clin Oncol; 2023 Jan; 149(1):263-270. PubMed ID: 36520216
[TBL] [Abstract] [Full Text] [Related]
2. Identification of C3 and FN1 as potential biomarkers associated with progression and prognosis for clear cell renal cell carcinoma.
Dong Y; Ma WM; Yang W; Hao L; Zhang SQ; Fang K; Hu CH; Zhang QJ; Shi ZD; Zhang WD; Fan T; Xia T; Han CH
BMC Cancer; 2021 Oct; 21(1):1135. PubMed ID: 34688260
[TBL] [Abstract] [Full Text] [Related]
3. Identification of a 6-Gene Signature Associated with Resistance to Tyrosine Kinase Inhibitors: prognosis for Clear Cell Renal Cell Carcinoma.
Li Q; Yang W; Lu M; Zhang R
Med Sci Monit; 2020 Dec; 26():e927078. PubMed ID: 33296352
[TBL] [Abstract] [Full Text] [Related]
4. Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis.
Obeng RC; Arnold RS; Ogan K; Master VA; Pattaras JG; Petros JA; Osunkoya AO
Int J Urol; 2020 Sep; 27(9):790-797. PubMed ID: 32638444
[TBL] [Abstract] [Full Text] [Related]
5. Development and validation of an individualized DNA repair-related gene signature in localized clear cell renal cell carcinoma.
Xiong Y; Qi Y; Lin W; Bai Q; Liu L; Guo J
World J Urol; 2021 Apr; 39(4):1203-1210. PubMed ID: 32458095
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of extensive necrosis in renal cell carcinoma.
Collins J; Epstein JI
Hum Pathol; 2017 Aug; 66():108-114. PubMed ID: 28669641
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
[TBL] [Abstract] [Full Text] [Related]
8. Receptors for advanced glycation end products (RAGE) is associated with microvessel density and is a prognostic biomarker for clear cell renal cell carcinoma.
Guo Y; Xia P; Zheng JJ; Sun XB; Pan XD; Zhang X; Wu CZ
Biomed Pharmacother; 2015 Jul; 73():147-53. PubMed ID: 26211596
[TBL] [Abstract] [Full Text] [Related]
9. Global gene expression profiling identifies aldh2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
Wu S; Chen J; Dong P; Zhang S; He Y; Sun L; Zhu J; Cheng Y; Li X; Tang A; Huang Y; Gui Y; Liu C; Yang G; Zhou F; Cai Z; Wang R
BMC Cancer; 2014 Nov; 14():836. PubMed ID: 25408144
[TBL] [Abstract] [Full Text] [Related]
10. Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria.
Zhang X; Zhu Z; Zhong S; Xu T; Shen Z
World J Urol; 2013 Feb; 31(1):155-60. PubMed ID: 22614444
[TBL] [Abstract] [Full Text] [Related]
11. Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker.
Dancer JY; Truong LD; Zhai Q; Shen SS
Arch Pathol Lab Med; 2010 Jan; 134(1):90-4. PubMed ID: 20073610
[TBL] [Abstract] [Full Text] [Related]
12. [Partial nephrectomy for renal cell carcinoma using a microwave tissue coagulator--postoperative recurrence and renal function].
Fujimoto K; Tanaka N; Hirao Y
Hinyokika Kiyo; 2005 Aug; 51(8):511-5. PubMed ID: 16164265
[TBL] [Abstract] [Full Text] [Related]
13. 31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma.
Süllentrop F; Moka D; Neubauer S; Haupt G; Engelmann U; Hahn J; Schicha H
NMR Biomed; 2002 Feb; 15(1):60-8. PubMed ID: 11840554
[TBL] [Abstract] [Full Text] [Related]
14. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
[TBL] [Abstract] [Full Text] [Related]
15. [Present status and controversy of treatment for renal cell carcinoma].
Ozono S; Takashima K; Yoshikawa M; Hirao Y; Okajima E
Hinyokika Kiyo; 1992 Nov; 38(11):1285-92. PubMed ID: 1485583
[TBL] [Abstract] [Full Text] [Related]
